Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 28.9%, EPS fell 17.3%, free cash flow grew 220.1% and total debt rose 47.7%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.

130.43 2.21 +1.72%
Market cap
$5.4B
P/E
0.0×
Fwd P/E
45.3×
Dividend yield
1.04%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100

Teleflex Incorporated (TFX) P/E ratio

Alert me on P/E ratio

Teleflex Incorporated has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 188× (December 2018) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 123× 271.51%
FY2023 33.0× 2.48%
FY2022 32.2× 1.78%
FY2021 31.7× (44.43%)
FY2020 57.0× 51.28%
FY2019 37.7× (36.00%)
FY2018 58.9× (21.87%)
FY2017 75.4× 159.97%
FY2016 29.0× 29.67%

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 188×
Ten-year median 33.0×
Current reading's percentile 9

P/E ratio against peers

Company P/E ratio
PLSE Pulse Biosciences, Inc compare n/m
BLCO Bausch + Lomb Corporation compare n/m
TFX Teleflex Incorporated n/m
ATR AptarGroup, Inc. compare 22.2×
STVN Stevanato Group S.p.A. compare 33.8×
MMSI Merit Medical Systems, Inc. compare 36.4×
NVST Envista Holdings Corporation compare 38.8×
ICUI ICU Medical, Inc. compare 136×
WRBY Warby Parker Inc. compare 334×
Medical Instruments & Supplies industry median 33.8×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on TFX